When we wrote our Second Quarter Newsletter, the domestic equity market had already made up much of the ground lost from COVID-19 related selloffs. Major stimuluses were passed, hospital beds, equipment, and materials to test and treat severe cases were in good supply, and new treatment strategies were showing promise.